Literature DB >> 28017145

Protein and Peptide Biopharmaceuticals: An Overview.

Dominic Agyei, Ishtiaq Ahmed, Zain Akram, Hafiz M N Iqbal, Michael K Danquah1.   

Abstract

Bioactive proteins and peptides are recognised as novel therapeutic molecules with varying biological properties for potential medical applications. Development of protein and peptidebased therapeutic products for human use is growing steadily as they continue to receive an increasing rate of approval by the United States Food and Drugs Administration (US FDA). In this short review, we describe the current status and methodologies involved in the synthesis of protein and peptide biopharmaceuticals with an emphasis on the drivers and restrains to their exploitation in the therapeutic products sector. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bioactive peptides; bioactive proteins; biopharmaceuticals; bioprocessing; therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28017145     DOI: 10.2174/0929866523666161222150444

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  7 in total

Review 1.  Development of Peptide Biopharmaceuticals in Russia.

Authors:  Vladislav I Deigin; Elena A Poluektova; Allan G Beniashvili; Sergey A Kozin; Yuri M Poluektov
Journal:  Pharmaceutics       Date:  2022-03-27       Impact factor: 6.525

2.  StraPep: a structure database of bioactive peptides.

Authors:  Jian Wang; Tailang Yin; Xuwen Xiao; Dan He; Zhidong Xue; Xinnong Jiang; Yan Wang
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

Review 3.  State-of-the-Art Extraction Methodologies for Bioactive Compounds from Algal Biome to Meet Bio-Economy Challenges and Opportunities.

Authors:  Juan Eduardo Sosa-Hernández; Zamantha Escobedo-Avellaneda; Hafiz M N Iqbal; Jorge Welti-Chanes
Journal:  Molecules       Date:  2018-11-12       Impact factor: 4.411

4.  Lipo-PEG-PEI complex as an intracellular transporter for protein therapeutics.

Authors:  Yu-Ling Lin; Chia-Hung Chen; Yen-Ku Liu; Tse-Hung Huang; Nu-Man Tsai; Shey-Cherng Tzou; Kuang-Wen Liao
Journal:  Int J Nanomedicine       Date:  2019-02-13

5.  The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension.

Authors:  Jinhwan Cho; Junyong Park; Giyoong Tae; Mi Sun Jin; Inchan Kwon
Journal:  Biomedicines       Date:  2020-04-26

Review 6.  Recombinant vaccines in 2022: a perspective from the cell factory.

Authors:  Marianna Teixeira de Pinho Favaro; Jan Atienza-Garriga; Carlos Martínez-Torró; Eloi Parladé; Esther Vázquez; José Luis Corchero; Neus Ferrer-Miralles; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2022-10-05       Impact factor: 6.352

7.  Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2.

Authors:  Qian Sun; Yinchen Shen; Li Su; Xun Xu
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.